Table 1. Factors involved in PBC and SSc pathogenesis.
PBC: primary biliary cholangitis; SSc: systemic sclerosis; TGF-β: transforming growth factor-beta; IL: interleukin; TNFα: tumor necrosis factor-alpha; EBV: Epstein-Barr virus; CMV: cytomegalovirus.
Factor | Source/trigger | Role in PBC | Role in SSc |
TGF-β [4,9,17] | Fibroblasts, immune cells | Promotes fibrosis and biliary epithelial cell injury | Promotes systemic fibrosis |
IL-6 [9,19] | Immune cells | Drives inflammation and fibrosis | |
TNFα [9,19] | Immune cells | Promotes disease progression and loss of self-tolerance | Type I collagen production by fibroblast and mediates vasculopathy and fibrosis |
IL-2R [9,19] | Immune cells | Decreases Treg cells and promotes autoimmunity | Secretes immunomodulatory factors by stimulating epithelial and endothelial cells and fibroblasts |
IL-17 [4,16] | Immune cells | Pro-inflammatory factor and induces inflammation | Alleviates immune and inflammatory response |
CD40L [16] | Immune cells | Regulates T-cell autoreactivity | Promotes autoimmunity |
Smoking [16,20] | Environmental | Increases oxidative stress and promotes autoimmunity | Enhances vascular damage and fibrosis |
UV exposure [16,20] | Environmental | Triggers DNA damage and promotes autoimmunity | Induces oxidative stress and promotes autoimmunity |
EBV, CMV [9,19] | Environmental | Triggers disease by molecular mimicry | Antibodies directed against viral protein UL94 cross reacts with NAG-2, expressed by endothelial cells and fibroblasts |
HDAC7 suppression [16,21] | Epigenetic | Decreases type I/III collagen production and modulates T-cell autoreactivity | Modulates fibrosis and immune responses |
H4ac [16,21] | Epigenetic | Induces CD40L and IL-17, suppresses the TNF-related apoptosis-inducing ligand (TRAIL), and regulates T-cell autoreactivity | Progression of disease activity |